Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Infectious Disease (3)
- Life Sciences (3)
- Medical Specialties (3)
- Bacterial Infections and Mycoses (2)
- Diseases (2)
-
- Pharmacy and Pharmaceutical Sciences (2)
- Public Health (2)
- Anatomy (1)
- Bacteriology (1)
- Biochemical Phenomena, Metabolism, and Nutrition (1)
- Chemical and Pharmacologic Phenomena (1)
- Chemicals and Drugs (1)
- Cognition and Perception (1)
- Community Health and Preventive Medicine (1)
- Complex Mixtures (1)
- Digestive System (1)
- Digestive, Oral, and Skin Physiology (1)
- Epidemiology (1)
- Fungi (1)
- Gastroenterology (1)
- Genetics and Genomics (1)
- Genomics (1)
- Immunology and Infectious Disease (1)
- Immunology of Infectious Disease (1)
- Laboratory Medicine (1)
- Medical Biochemistry (1)
- Medical Microbiology (1)
- Institution
Articles 1 - 5 of 5
Full-Text Articles in Organisms
Oral Dosages Of The Nsaid Aspirin Decreased The Growth Rate Of Species Found In The Human Gut Microbiome Including Akkermansia Muciniphila, Bacteroides Fragilis, Clostridium Sordellii, And Clostridium Difficile, Wyatt H. Greenbaum, Garrett J. Greenbaum, Anna Spiezio
Oral Dosages Of The Nsaid Aspirin Decreased The Growth Rate Of Species Found In The Human Gut Microbiome Including Akkermansia Muciniphila, Bacteroides Fragilis, Clostridium Sordellii, And Clostridium Difficile, Wyatt H. Greenbaum, Garrett J. Greenbaum, Anna Spiezio
PANDION: The Osprey Journal of Research and Ideas
Over past few decades, new insight has been revealed in the scientific community about the importance of the human gut microbiome relating to general health. It is known that imbalances in the species that reside in the human gut can cause organism-wide problems in humans. When prescribing or injecting oral medications, the thought of the downstream effects on the gut microbiome are not always considered. By exposing known healthy members of the gut; Akkermansia muciniphila, Bacteroides fragilis, Clostridium sordellii, and Clostridium difficile to the Aspirin, this study attempted to provide insight into the effects of the drug on bacterial growth. …
The Last Of Us In Therapy: How Mind-Controlling Fungi And Gut Bacteria Affect Your Mental Health, Anastasia Lyon
The Last Of Us In Therapy: How Mind-Controlling Fungi And Gut Bacteria Affect Your Mental Health, Anastasia Lyon
Journal of Pharmacology & Nutritional Sciences
The "psilocybiome" represents the mutually beneficial relationship between ourselves, our bacteria, and psychedelic drugs. This short review briefly discusses the benefits and limitations surrounding the potential for psychedelic therapy to synergize with gut bacteria to help regulate and maintain proper balance in the immune system, diet, and stress levels. Psychedelic therapy is a novel treatment strategy that has the potential to improve patient mental health, and, by identifying the types of gut bacteria present in patients, it can aid in personalizing medicine by determining how well their "psilocybiome" may respond.
The Large And Small Of It: The Microbiome And Metagenomics, Austin Hopkins, Elaina Gollmar, Jessica Fernandez, Shawn Wolf, Austin Hilverding, Andrew M. Roecker
The Large And Small Of It: The Microbiome And Metagenomics, Austin Hopkins, Elaina Gollmar, Jessica Fernandez, Shawn Wolf, Austin Hilverding, Andrew M. Roecker
Pharmacy and Wellness Review
Metagenomics, the analysis of the microbial genome, permits scientists to understand the influences of external sources including diet, metabolism and antibiotics on the human microbiome. Research has revealed the possibility of a core symbiosis between humans and bacteria. The main role of the human microbiome is to aid in digestion, but identified ancillary roles include immunologic homeostasis and infection prevention. Quantifying the composition and variability of the microbiome will help lead to future treatments or preventive strategies against unhealthy change. A variety of methods may be used to define the microbiome, and 16S amplicon sequencing is primarily utilized today. Probiotics …
Increasing Antibiotic Resistance In Shigella Bacteria In The United States, William J. Pharr
Increasing Antibiotic Resistance In Shigella Bacteria In The United States, William J. Pharr
The Corinthian
Shigella bacteria cause half a million infections, 6,000 hospitalizations, and 70 deaths annually in the United States. These bacteria are of particular concern due to their high survivability, low infectious dose, and high adaptability. Cases of shigellosis from Shigella sonnei are becoming a more prevalent issue in the U.S. as the bacteria continues to develop higher resistance to today’s strongest antibiotics. Much of this resistance is connected to the exchange of genes between strains of Shigella due to insertion sequences (IS), intercontinental travel, and men who have sex with men (MSM). As a result of increased resistance, the use of …
Epidemiology Crucial To Cracking Elizabethkingia Crisis, Angela Tonozzi
Epidemiology Crucial To Cracking Elizabethkingia Crisis, Angela Tonozzi
Journal of Patient-Centered Research and Reviews
The author explains the epidemiological methods, tools and personnel required to pinpoint the source of Wisconsin’s 2016 outbreak of Elizabethkingia infections.